 SAN DIEGO, Oct. 27, 2020 GLOBE NEWSWIRE -- aTyr Pharma, Inc. Nasdaq: LIFE, a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer, will participate in a panel titled, Immune Modulators to Ameliorate COVID-19 as part of the ROTH Capital Partners Webinar on COVID-19 Therapeutics in Development on October 28, 2020. 